Skip to content

Addiction: all studies

Page 88 of 860: studies 871 to 880 of 8,594, newest first. Back to the addiction overview

Research

Women and MDMA: particularities of gender and sex.

International Review of Psychiatry 2023 Fabio Carezzato, Ilana Falcão de Arruda, Caio Petrus Monteiro Figueiredo et al. 4 citations

This comprehensive review delves into the intricate interplay between gender/sex and MDMA use, drawing upon recent evidence. It explores how girls, as a means of coping with negative emotions, often resort to drug use, while boys primarily initiate drug use due to peer pressure or sensation-seeking tendencies. Women, frequently having endured traumatic life events, may turn to MDMA as a form of...

Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico.

Journal of Psychoactive Drugs 2023 Anja Loizaga-Velder, Cecile Giovannetti, Ricardo Campoy Gomez et al. 9 citations

This paper describes three case studies from an outpatient intercultural therapeutic program founded and run by Yaqui health professionals and traditional healers to serve members of the Yaqui tribe residing in Sonora, Mexico. This pilot therapeutic program has been designed specifically for Indigenous individuals, incorporating the ceremonial use of naturally derived psychedelics in addressing...

Co-Occurring Subacute Combined Degeneration and Guillain-Barré Syndrome Resulting From Nitrous Oxide Abuse: A Case Report.

Cureus December 1, 2022 Kristen Strom, Ateaya Lima, Vahideh Tabarzadi

Growing in prevalence as a recreational drug of abuse across a broad scope of people, nitrous oxide (N2O) has proven to be a public health concern. Side effects of its abuse have a great degree of variation among people ranging from neurologic, psychiatric, and medical symptoms. We present a rare case of a 23-year-old female with a history of N2O abuse, who presented with symptoms of both...

Psilocybin‐assisted therapy reduces heavy drinking in patients with AUD

The Brown University Psychopharmacology Update November 3, 2022

Two sessions of psilocybin‐assisted psychotherapy resulted in reduced heavy‐drinking days and other alcohol‐related problems relative to placebo plus psychotherapy in a randomized trial involving patients with alcohol use disorder (AUD). There were no serious adverse events associated with psilocybin administration, and no signs of psychotic disturbances. Study results were published online...

Psilocybin treatment for AUD: Promise in new study

Alcoholism & Drug Abuse Weekly October 14, 2022 Alison Knopf

The beneficial effects of psilocybin‐assisted psychotherapy on alcohol use disorder (AUD) are significant, based on a study published in JAMA Psychiatry last month. In general, psychedelic medications have been a focus of research, but less is known about psilocybin, and it has been 40 years since the studies with lysergic acid diethylamide (LSD) provided double the remissions as comparison...

Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review.

Biomolecules October 12, 2022 Justin Matheson, Zoe Bourgault, Bernard Le Foll

Cannabidiol (CBD) is a non-intoxicating cannabinoid compound with diverse molecular targets and potential therapeutic effects, including effects relevant to the treatment of psychiatric disorders. In this scoping review, we sought to determine the extent to which sex and gender have been considered as potential moderators of the neuropsychiatric effects and pharmacokinetics of CBD. In this...

Snake venom - An unconventional recreational substance for psychonauts in India.

Journal of Forensic and Legal Medicine October 1, 2022 Devendra Jadav, Rutwik Shedge, Vikas P Meshram et al.

Psychoactive substances have been used by humankind for recreational purposes since time immemorial. The psychoactive properties of these substances are known to alter the consciousness, mood, and perception of people taking them. While the use of alcohol, opioids, and cannabinoids for recreational purposes has been researched thoroughly, cases of using psychoactive fauna or animal body parts...

DOI: 10.1016/j.jflm.2022.102398 (opens in new tab) Full text (opens in new tab) Addiction Psychoactive fauna Psychoactive substance Snake venom +1

Potential Therapeutic Effects of Psilocybin: A Systematic Review.

Cureus October 1, 2022 Dev B Goel, Sarju Zilate 24 citations

Psilocybin is a plant alkaloid that is derived from precursors of tryptamine and is present in many different types of mushrooms. It has been utilized by indigenous peoples of Central and South America for centuries in a ceremonial setting to promote spiritual experiences. Indigenous societies have long employed psilocybin and other 5-HT 2A agonist classic psychedelics in their rites. They were...

Experiences of Listening to Icaros during Ayahuasca Ceremonies at Centro Takiwasi:An Interpretive Phenomenological Analysis

Anthropology of Consciousness September 26, 2022 Owain J. Graham, Gary Rojas Saucedo, Matteo Politi 11 citations

Abstract Research on psychedelic‐assisted psychotherapy has shown that music affects therapeutic outcomes at a fundamental level. The development of such therapies calls for research on the use of music with consciousness‐altering substances, especially in contexts informed by their traditional use. Informed by ethnographic reports, our project answers this call, investigating the phenomenology...

Christianity and Psychedelic Medicine: A Pastoral Approach

Christian bioethics Non-Ecumenical Studies in Medical Morality September 19, 2022 Bryan Mccarthy 12 citations

Abstract In recent years, researchers in the “psychedelic renaissance” have been reinvestigating the therapeutic potential of psychedelic compounds for conditions like post-traumatic stress disorder, clinical anxiety/depression, and addiction. Each of these has treatment-resistant cases, sometimes decades in the making, but studies employing psychedelics to address them are yielding impressive...